NO923769D0

Iontophoretic drug delivery system with two-stage delivery profile.

Abstract

A two-stage iontophoretic drug delivery system provides that iontophoretic current is delivered at a first level for a first predetermined interval to rapidly introduce a therapeutic agent into the bloodstream and thereafter reduced to a second lower level to maintain a desired steady-state therapeutic level of the agent. One embodiment provides that the initial interval is maintained sufficiently long to provide a peak dosage, thereafter which the current is shut off to allow concentration of the agent to subside in the bloodstream, whereupon a maintenance level of iontophoretic current is initiated. Another embodiment provides that the patient may selectively initiate a brief interval of increased iontophoretic current level to attain a brief interval of increased dosage.

Term

No projected expiry on record.

  1. Priority
  2. Filed and published
  3. Today

23 members in 14 offices

This recordMember, by publication datePriority claim4 more offices are in the list below

Priority claims9

Priority claims
DocumentOfficeKindDate
50217690United States of AmericaA
67130691United States of AmericaA
9101941United States of AmericaW
502176
671306
US19900502176
US19910671306
US9101941
WO1991US01941

Members23

Family members, oldest first
DocumentOfficeKind
CA2079316A1CanadaA1
WO9115258A1World Intellectual Property Organization (WIPO)A1
AU7991591AAustraliaA
FI924352AFinlandA
NO923769D0This recordNorwayD0
NO923769LNorwayL
EP0522092A1European Patent Office (EPO)A1
KR930700181ARepublic of KoreaA
US5207752AUnited States of AmericaA
AU638581B2AustraliaB2
JPH05505964AJapanA
EP0522092B1European Patent Office (EPO)B1
AT114118TAustriaT
DE69105202D1GermanyD1
DK0522092T3DenmarkT3
DE69105202T2GermanyT2
ES2067939T3SpainT3
GR3015116T3GreeceT3
KR0169084B1Republic of KoreaB1
NO308025B1NorwayB1
JP3181289B2JapanB2
CA2079316CCanadaC
FI110066BFinlandB